Queen Mary University of London

The firm will hold the intellectual property for its cell capture and analysis technology as QMUL files patents for recent findings using the Parsortix system.

The International Mouse Phenotyping Consortium has systematically studied knockout mice to find new disease models and candidate disease genes.

New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.

DNA methylation changes at two markers can differentiate anal cancer and high-grade anal intraepithelial neoplasms from low-grade and benign samples.

A number of these loci were linked to blood pressure medication targets, and the researchers developed a genetic risk score.

British researchers examined ash dieback disease susceptibility markers among ash trees in the UK and continental Europe.

Exome sequencing data for hundreds of testicular germ cell tumor patients led to the discovery of rare mutations affecting cilia-microtubule genes.

Tapping data for hundreds of thousands of individuals, three teams uncovered overlaps between blood pressure and other metabolic and immune traits.

Investigators looked at potential health impacts for the rare, homozygous loss-of-function mutations they detected in 3,200 British-Pakistani individuals.

Three Markers

A Queen Mary University of London-led team reports on a three-protein biomarker panel for early stage pancreatic cancer.

Pages

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.